Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paiteling Antibacterial Liquid in Persistent Cervical HR-HPV Infection
NCT07493824Phase 4Recruiting
- Sponsor
- The First Hospital of Jilin University
- Start
- Jul 2025
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Paiteling in cervical human papillomavirus infection, sponsored by The First Hospital of Jilin University. Started Jul 2025; status: recruiting.
02
Drugs
Paiteling
03
Conditions
cervical human papillomavirus infection
Beyond the preview
Go deeper on NCT07493824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07493824.